These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6011791)

  • 21. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. II. Influence on behaviour in rats.
    Kazdová E; Metysová J; Dlabac A
    Act Nerv Super (Praha); 1971; 13(3):186-7. PubMed ID: 5113831
    [No Abstract]   [Full Text] [Related]  

  • 22. Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?
    Costall B; Naylor RJ
    Psychopharmacologia; 1973; 32(2):161-70. PubMed ID: 4796282
    [No Abstract]   [Full Text] [Related]  

  • 23. [Electroencephalographic studies of a triflumethyl-phenothiazine derivative].
    Itil TM
    Arzneimittelforschung; 1965 Jul; 15(7):817-9. PubMed ID: 5898686
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological studies on the brain mechanisms underlying two forms of behavioral excitation: stereotyped hyperactivity and "rage".
    Randrup A; Munkvad I
    Ann N Y Acad Sci; 1969 Jul; 159(3):928-38. PubMed ID: 4902868
    [No Abstract]   [Full Text] [Related]  

  • 25. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 26. Definition and classification of neuroleptics.
    Arnold OH; Collard J; Deniker P; Ginestet D; Hippius H; Itil TM; Labhardt F; Leeds AA; Montanini R; Morozov G; Simon P; Villeneuve A
    Mod Probl Pharmacopsychiatry; 1970; 5():141-7. PubMed ID: 5527163
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of intraventricularly administered prostaglandin E1 on the electrical activity of cerebral cortex and behavior in the unanesthetized monkey.
    Desiraju T
    Prostaglandins; 1973 Jun; 3(6):859-70. PubMed ID: 4199677
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of chronic administration of neuroleptics: dyskinesias in monkeys.
    Paulson G
    Pharmacol Ther B; 1976; 2(1):167-71. PubMed ID: 4829
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacological profile of a new psychotherapeutic agent: 4-p-fluorophenyl-5-N(N'-o-methoxyphenyl)piperazinoethyl-4-oxazolin-2-one (LR 511).
    Fregnan GB; Vidali M
    Pharmacology; 1977; 15(6):485-502. PubMed ID: 563604
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of extrapyramidal manifestations induced by neuroleptics].
    Bordeleau JM; Tétreault L
    Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291
    [No Abstract]   [Full Text] [Related]  

  • 31. Behavioural effects in rats of morphine and amphetamine and of a combination of the two drugs.
    Fog R
    Psychopharmacologia; 1970; 16(4):305-12. PubMed ID: 5461437
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats.
    Chandra O; Bernard J; Matussek N
    Arzneimittelforschung; 1974 Nov; 24(11):1821-4. PubMed ID: 4480057
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of phenothiazine derivatives on the sleep-wakefulness cycle in growing kittens.
    Shimizu A; Himwich HE
    Folia Psychiatr Neurol Jpn; 1968; 22(4):297-305. PubMed ID: 5756541
    [No Abstract]   [Full Text] [Related]  

  • 34. The antisialogogue effect of phenothiazine derivatives: comparison of pecazine, perphenazine, fluphenazine, thiopropazate, pipamazine and triflupromazine.
    DOBKIN AB; PURKIN N
    Br J Anaesth; 1960 Feb; 32():57-9. PubMed ID: 13817061
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuropharmacological properties of some substituted gamma-butyrolactones.
    Hano J; Trabka J; Sieroslawska J
    Arch Immunol Ther Exp (Warsz); 1968; 16(1):137-54. PubMed ID: 5651518
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug therapy.
    Stone WN; Hofling CK; Winslow WW
    Prog Neurol Psychiatry; 1971; 26():529-51. PubMed ID: 4274994
    [No Abstract]   [Full Text] [Related]  

  • 37. A rational framework for the development, evaluation, and use of psychoactive drugs.
    Irwin S
    Am J Psychiatry; 1968 Feb; 124(8):Suppl:1-19. PubMed ID: 4865729
    [No Abstract]   [Full Text] [Related]  

  • 38. Spiranes. XII. Azaspiranylalkylphenothiazines.
    Grogan CH; Kelly R; Rice LM
    J Med Chem; 1966 Sep; 9(5):654-6. PubMed ID: 5969032
    [No Abstract]   [Full Text] [Related]  

  • 39. 10-N substituted phenothiazine derivatives in auricular arrhythmias.
    Singh KP; Sharma VN
    Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):168-78. PubMed ID: 5353874
    [No Abstract]   [Full Text] [Related]  

  • 40. [EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA].
    BOHACEK N; HAJNSEK F; SARTORIUS N
    Fortschr Neurol Psychiatr Grenzgeb; 1963 Oct; 31():565-70. PubMed ID: 14095902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.